Asset management company Artisan Partners on Wednesday divested a 1.2% stake in telecom infrastructure major Indus Towers for Rs 717 crore ...

American venture capital firm Sequoia Capital has exited Quick Heal Technologies Ltd, by selling its entire 3.4% stake in the company throu...

Piramal Pharma's shares rose 10.2% on BSE after the US FDA concluded its inspection at the company’s Sellersville manufacturing facility. T...

Stressing that maintaining a strong focus on quality and compliance is another important area of growing significance in the pharma sector,...

Aurobindo Pharma plunged 19% after USFDA flagged lack of good manufacturing practices at the Telangana plant.

The Nifty Pharma index was trading 2.43 per cent up at 10,644 around 10:45 am.

Cadila Healthcare, Aurobindo Pharma and Piramal Enterprises plunged up to 3 per cent.

Shares of Sun Pharma plunged on reports of USFDA inspection of its Halol plant in Gujarat.

21 stocks that hit fresh 52-week lows on NSE in Tuesday's trade so far.

There is no further update on IDFC- Shriram Group merger, says Piramal

Nifty Pharma index was down 52 points at 9,425 around 2 pm.

If you see, some of the observations they make for some of the FDA stoppages that they have done, these are all public, says the Chairman o...

The company had posted a net profit after tax, minority interest and share of profit of associates of Rs 169.43 crore for the corresponding...

While most pharma companies have turned risky on account of regulatory clamps, investors have switched to companies with healthy pipeline a...

Indian pharma companies say they don’t expect any negative effects on their business prospects in the US.

Nicholas Piramal plans to take up oncology market on its own for its anti-blood cancer drug.

Nicholas Piramal announced on Monday that it had received approval from the USFDA to start clinical trials on humans for its new cancer dru...